A Cheshire biotech start-up has raised $65m after floating in New York.
Zura Bio. which specialises in developing drugs for immune system disorders, is led by Dr Someit Sidhu and has merged with special purpose acquisition company (SPAC) JATT acquisition corp to complete the deal.
The funds raised will go towards its research and development pipeline.